Pharmaceuticals

Therapeutic BCG Vaccines Industry Poised for Rapid Growth, Forecast to Touch $80.4 Billion by 2030 at 6.4% CAGR

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the therapeutic bcg vaccines market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Therapeutic BCG Vaccines Market between 2026 and 2030?

The therapeutic bcg vaccines market size has seen significant expansion in recent years. This market is set to increase from $59.09 billion in 2025 to $62.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. Historically, this growth can be attributed to factors like high tb prevalence, rising research in immunotherapy, limited vaccination coverage, government health initiatives, and awareness of bcg benefits.

The therapeutic bcg vaccines market size is anticipated to undergo significant expansion in the next few years. It is predicted to attain a value of $80.4 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This projected growth throughout the forecast period is driven by factors such as a heightened demand for personalized vaccines, innovations in vaccine delivery technology, an increasing emphasis on immuno-oncology applications, the expansion of public health initiatives, and rising investments in biotech advancements. Notable trends during this timeframe are expected to include the development of personalized bcg therapies, breakthroughs in vaccine delivery, expanded research into tb immunotherapy, the adoption of combination therapies involving bcg, and government-sponsored immunization programs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9178&type=smp

Which Drivers Are Expected To Impact The Therapeutic BCG Vaccines Market During The Forecast Period?

The global surge in tuberculosis (TB) infections is set to fuel the expansion of the therapeutic BCG vaccine market. Tuberculosis (TB) stands as a potentially hazardous infectious disease that predominantly affects the lungs. Its transmission occurs person-to-person through airborne bacterial droplets released during coughing or sneezing. BCG vaccines work by stimulating the immune system to combat infections, without causing TB due to their weakened germs. This vaccine consistently provides defense against severe forms of TB, including adolescent TB meningitis. The protective action of the BCG vaccine against tuberculosis helps in fighting off infection, leading to a rise in the application of therapeutic BCG vaccines. As an illustration, in February 2024, a report from the UK Health Security Agency, a UK-based government body, indicated a 10.7% increase in tuberculosis (TB) cases in England during 2023, with 4,850 reported cases compared to 4,380 in 2022. Consequently, the growing incidence of tuberculosis (TB) globally is propelling the growth of the therapeutic BCG vaccine market.

How Is The Therapeutic BCG Vaccines Market Divided Into Segments?

The therapeutic bcg vaccines market covered in this report is segmented –

1) By Type: Therapy BCG, Other Types

2) By Demographics: Pediatrics, Adults

3) By End Use: Hospitals, Clinics, Other End Users

Which Trends Are Influencing The Performance And Direction Of The Therapeutic BCG Vaccines Market?

Major companies within the therapeutic BCG vaccine market are concentrating on innovating vaccines for potential therapeutic uses across diverse medical conditions, such as BCG immunotherapy, with the goal of expanding their customer base and addressing increasing patient requirements. BCG (Bacillus Calmette-Guérin) immunotherapy refers to the application of the BCG vaccine as a form of immunotherapy primarily for treating specific types of cancer, particularly bladder cancer. For instance, in July 2023, The Serum Institute of India, an India-based biotechnology and biopharmaceuticals company, obtained government approval to export its BCG vaccine to Canada for immunotherapeutic application in treating bladder cancer. This live, freeze-dried preparation, derived from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin), is indicated for intravenous instillation, and the vaccine is available in 40 mg and 80 mg presentations. As a fundamental aspect of the therapy, the vaccine is administered directly into the bladder through a catheter, where it remains within the bladder lining for a specified duration. This targeted methodology aims to effectively impact cancer cells while minimizing effects on other bodily regions.

Which Key Players Are Driving Competition In The Therapeutic BCG Vaccines Market?

Major companies operating in the therapeutic bcg vaccines market are Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, Bharat Biotech International Ltd., Shanghai Institute of Biological Products Co. Ltd., Instituto Butantan, BioCen, Panacea Biotec Ltd., Institute Pasteur de Tunis, Korean BCG Vaccine Institute

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Which Region Is Projected To Lead The Therapeutic BCG Vaccines Market During The Forecast Period?

Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2025. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Therapeutic BCG Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9178&type=smp

Browse Through More Reports Similar to the Global Therapeutic BCG Vaccines Market 2026, By The Business Research Company

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795